checkAd

     101  0 Kommentare Zai Lab Announces Participation in May and June Investor Conferences

    Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in May and June 2024:

    J.P. Morgan 20th Annual Global China Summit
    Panel Discussion: Thursday, May 23, 2024, 10:00 a.m. HKT
    Location: Shanghai, China

    Jefferies Global Healthcare Conference
    Fireside Chat: Wednesday, June 5, 2024, 3:30 p.m. ET in Track 2
    Location: New York, New York

    Goldman Sachs 45th Annual Global Healthcare Conference
    Presentation: Wednesday, June 12, 2024, 1:20 p.m. ET
    Location: Miami Beach, Florida

    About Zai Lab

    Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious diseases, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.

    For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.


    The Zai Lab Stock at the time of publication of the news with a fall of -3,52 % to 19,20EUR on Tradegate stock exchange (15. Mai 2024, 22:26 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Zai Lab Announces Participation in May and June Investor Conferences Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in May and June 2024: J.P. Morgan 20th Annual Global China Summit Panel …

    Schreibe Deinen Kommentar

    Disclaimer